SRZN - Financial Reports List - Surrozen, Inc. - IntrinsicAlpha

Surrozen, Inc. SRZN

Healthcare - Biotechnology - NASDAQ - US

$ 10.3

0.313 %

$ 87.5 M

Market Cap

-0.44

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	-84.20%	-214.59%	11.28%
Annual Report	FY	10-K	2024-12-31	0.00%	-47.68%	44.21%
Quarterly Report	Q3	8-K	2024-09-30	0.00%	86.27%	111.01%
Quarterly Report	Q2	8-K	2024-06-30	0.00%	-169.11%	11.93%
Quarterly Report	Q1	8-K	2024-03-31	0.00%	44.58%	37.43%
Quarterly Report	Q4	8-K	2023-12-31	-66.83%	-121.90%	-346.47%
Annual Report	FY	10-K	2023-12-31	0.00%	-55.56%	-3.25%
Quarterly Report	Q3	8-K	2023-09-30	0.00%	21.80%	17.76%
Quarterly Report	Q2	8-K	2023-06-30	0.00%	31.87%	26.98%
Quarterly Report	Q1	8-K	2023-03-31	0.00%	-1037.33%	-0.68%

1